IVI Bilbao   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Leioa Spain (1990)

Organization Overview

First Clinical Trial
2015
NCT02503605
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

IVI Bilbao